Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus subversion of protective immunity.

Eric W Hewitt1, Gillian E Dugan

  • 1School of Biochemistry and Microbiology, University of Leeds, Leeds, LS2 9JT, UK. e.w.hewitt@leeds.ac.uk

Current Allergy and Asthma Reports
|July 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single molecule delivery into living cells.

Nature communications·2024
Same author

Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection.

Frontiers in molecular neuroscience·2020
Same author

Macromolecular Crowding Enhances the Detection of DNA and Proteins by a Solid-State Nanopore.

Nano letters·2020
Same author

Structural mapping of oligomeric intermediates in an amyloid assembly pathway.

eLife·2019
Same author

A new era for understanding amyloid structures and disease.

Nature reviews. Molecular cell biology·2018
Same author

Why are Functional Amyloids Non-Toxic in Humans?

Biomolecules·2017
Same journal

Harnessing Machine Learning and Electronic Health Record Data to Improve Asthma Management.

Current allergy and asthma reports·2026
Same journal

Incorporating New Guidelines into School-Based Asthma Management.

Current allergy and asthma reports·2026
Same journal

The Modern Environment and Childhood Asthma: The Role of Air Pollution and Heavy Metal Exposure.

Current allergy and asthma reports·2026
Same journal

Targeting Type 2 and Non-type 2 Asthma: Emerging Biologics and Personalized Strategies.

Current allergy and asthma reports·2026
Same journal

The Role of the Indoor Exposome in Food Allergy Development.

Current allergy and asthma reports·2026
Same journal

Understanding Infantile Atopic Dermatitis: A Review of Environmental, Familial, Genetic and Microbial Influences.

Current allergy and asthma reports·2026
See all related articles

Viruses can evade immune responses by blocking the Major Histocompatibility (MHC) class I pathway, which normally presents viral peptides to cytotoxic T lymphocytes (CTLs). This review details viral strategies that inhibit MHC class I antigen presentation to escape CTL-mediated killing.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • The Major Histocompatibility (MHC) class I antigen presentation pathway is crucial for cellular immunity against viruses.
  • MHC class I molecules present intracellular peptides to cytotoxic T lymphocytes (CTLs) for immune surveillance.
  • Viral infections are often cleared by CTLs recognizing viral peptides presented by MHC class I molecules.

Purpose of the Study:

  • To review recent findings on how viruses inhibit the MHC class I antigen presentation pathway.
  • To understand the mechanisms viruses employ to evade CTL-mediated lysis.
  • To highlight the evolutionary strategies of viruses to counteract host antiviral immunity.

Main Methods:

  • This is a review article, synthesizing existing research.

Related Experiment Videos

  • Literature search and analysis of studies on viral inhibition of MHC class I.
  • Compilation of data on viral proteins and their interactions with the MHC class I pathway.

    • Main Results:

    • Many viruses have evolved specific proteins that interfere with the MHC class I pathway.
    • Viral inhibition mechanisms target various stages of antigen processing and presentation.
    • Successful viral inhibition allows infected cells to escape detection and elimination by CTLs.

    Conclusions:

    • Viral evasion of the MHC class I pathway is a common and effective immune escape strategy.
    • Understanding these viral mechanisms is vital for developing antiviral therapies.
    • Further research into viral immune evasion can inform vaccine design and immunotherapy.